Skip to content
  • Bioequivalence
  • Community
  • Investors

Now providing Mesenchymal cell-based immunomodulation for Covid19-induced hypercytokinemia. Call us to learn more

Somata
Genesis Biopharmaceuticals
  • Covid-19
    • Clinical Trials
    • Products
      • Ventilator
  • Treatments
    • Neurodegenerative Diseases
      • Multiple sclerosis
      • Amyotrophic lateral sclerosis
      • Parkinson’s disease
      • Cerebral palsy
      • Autism
    • Diabetes T2
    • Critical limb ischemia
    • Kidney disorder
    • Stroke
  • Biopharmaceuticals
    • Neutrojen
    • Somajen
    • Stem cells
  • Services
    • Bioequivalence
    • Pharmacokinetics
  • Discoveries
    • Multiple Sclerosis
    • COVID-19

Day: May 4, 2018

Cancer Institute Finally Admits Marijuana Kills Cancer
Articles

Cancer Institute Finally Admits Marijuana Kills Cancer

Cancer kills nearly 600,000 Americans per year. And this year alone, over 1.6 million people will be diagnosed. So much time and research has gone into the cure of cancer in the last few decades. Yet, because of…

by admin
- May. 04, 2018
chat_bubble_outline0
Read morearrow_forward
https://www.facebook.com/somatagenesis
PO Box 66 Albion ID 83311, USA
International +91 992 149 6595
USA +1 646 583 1660
info@somatagenesis.com
  • Neutrojen
  • Somajen
  • Stem cells
  • Bioequivalence
  • Contact
  • COVID-19
  • Multiple Sclerosis Research
Copyright © 2025 Somata Genesis, Inc. | 416, Burlington Tower, Business Bay, Dubai, United Arab Emirates
  • Facebook
  • LinkedIn
  • Twitter